[HTML][HTML] One hundred years of chronic obstructive pulmonary disease (COPD)
M Cazzola, CF Donner, NA Hanania - Respiratory medicine, 2007 - Elsevier
Chronic obstructive pulmonary disease (COPD) is an increasing health problem and one of
the leading causes of morbidity and mortality worldwide, but knowledge about its …
the leading causes of morbidity and mortality worldwide, but knowledge about its …
Emerging trends in the therapy of COPD: bronchodilators as mono-and combination therapies
MF Fitzgerald, JC Fox - Drug discovery today, 2007 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease that is
characterized by progressive airway obstruction that, unlike asthma, is relatively insensitive …
characterized by progressive airway obstruction that, unlike asthma, is relatively insensitive …
A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD
M Cazzola, F Andò, P Santus, P Ruggeri… - Pulmonary …, 2007 - Elsevier
The aim of this pilot study was to explore the relative efficacy in terms of improvement in
symptoms and lung function of combining fluticasone propionate/salmeterol combination …
symptoms and lung function of combining fluticasone propionate/salmeterol combination …
[HTML][HTML] A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
T Fardon, K Haggart, DKC Lee, BJ Lipworth - Respiratory medicine, 2007 - Elsevier
We conducted a double blind, randomised, placebo-controlled, crossover study evaluating
the effects of halving inhaled steroid dosage plus salmeterol, or salmeterol and tiotropium …
the effects of halving inhaled steroid dosage plus salmeterol, or salmeterol and tiotropium …
Efficacy and safety of tiotropium in COPD patients in primary care–the SPiRiva Usual CarE (SPRUCE) study
D Freeman, A Lee, D Price - Respiratory research, 2007 - Springer
Background Clinical trials of tiotropium have principally recruited patients from secondary
care with more severe chronic obstructive pulmonary disease (COPD), and typically had …
care with more severe chronic obstructive pulmonary disease (COPD), and typically had …
Role of tiotropium in the treatment of COPD
KL Rice, KM Kunisaki… - International journal of …, 2007 - Taylor & Francis
Tiotropium is a potent, long-acting, selective anticholinergic bronchodilator. Treatment with
tiotropium produces sustained improvements in lung function, particularly FEV1 (peak …
tiotropium produces sustained improvements in lung function, particularly FEV1 (peak …
[HTML][HTML] The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study
M Cazzola, MG Matera - Respiratory medicine, 2007 - Elsevier
We explored the additive effect of titrated oral theophylline in patients with stable chronic
obstructive pulmonary disease (COPD) who received both tiotropium, 18μg od, and …
obstructive pulmonary disease (COPD) who received both tiotropium, 18μg od, and …
The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease
SW Um, CG Yoo, YW Kim, SK Han… - Journal of Korean …, 2007 - synapse.koreamed.org
Because additive effects of inhaled corticosteroids and long-acting anticholinergics are
unclear, we undertook this study to compare the efficacy of tiotropium alone and tiotropium …
unclear, we undertook this study to compare the efficacy of tiotropium alone and tiotropium …
Premature discontinuation of patients: a potential bias in COPD clinical trials
S Kesten, M Plautz, CA Piquette… - European …, 2007 - Eur Respiratory Soc
Premature discontinuation from clinical trials may bias results against effective therapies. In
the present study mortality rates were retrospectively reviewed in a 6-month, randomised …
the present study mortality rates were retrospectively reviewed in a 6-month, randomised …
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids
R Hodder, S Kesten, S Menjoge… - International Journal of …, 2007 - Taylor & Francis
Patients with COPD are frequently prescribed inhaled corticosteroids (ICS); however, it is
unclear whether the treatment with ICS might modify responses to inhaled bronchodilators …
unclear whether the treatment with ICS might modify responses to inhaled bronchodilators …